Table 5.

Comparison of the clinical and immunologic characteristics of the BCR-ABL+ and BCR-ABL patients

CharacteristicsBCR-ABL5-150
n = 257 (%)
BCR-ABL+5-150
n = 175 (%)
P
Age (y)    
 15-20 64  (25) 8  (5) .0015-151 
 20-50 141  (55) 98  (56)  
 50-65 52  (20) 69  (39)  
 Median 30  (15-64) 45  (15-65) .00015-152 
WBC (× 109/L)5-153    
 < 30 000 185  (72) 97  (55) .0015-155 
 > 30 000 71  (28) 78  (45)  
 Median 11 550
(22-720 000) 
23 500
(1500-3 531 000) 
.00015-152 
Granulocytes (× 109/L)    
 Median 1080  (0-28 400) 2219  (0-494 340) .00015-152 
Hemoglobin (g/dL)    
 Median 9.2  (2.5-16) 10.2  (3-16.3) .0045-152 
Immunophenotype    
 CD34 > 20% 169  (66) 164  (94) .0015-155 
 CD13 > 20%5-154 36  (14) 46  (27) .0015-155 
 CD33 > 20%5-159 45  (18) 126  (27) .0015-155 
CharacteristicsBCR-ABL5-150
n = 257 (%)
BCR-ABL+5-150
n = 175 (%)
P
Age (y)    
 15-20 64  (25) 8  (5) .0015-151 
 20-50 141  (55) 98  (56)  
 50-65 52  (20) 69  (39)  
 Median 30  (15-64) 45  (15-65) .00015-152 
WBC (× 109/L)5-153    
 < 30 000 185  (72) 97  (55) .0015-155 
 > 30 000 71  (28) 78  (45)  
 Median 11 550
(22-720 000) 
23 500
(1500-3 531 000) 
.00015-152 
Granulocytes (× 109/L)    
 Median 1080  (0-28 400) 2219  (0-494 340) .00015-152 
Hemoglobin (g/dL)    
 Median 9.2  (2.5-16) 10.2  (3-16.3) .0045-152 
Immunophenotype    
 CD34 > 20% 169  (66) 164  (94) .0015-155 
 CD13 > 20%5-154 36  (14) 46  (27) .0015-155 
 CD33 > 20%5-159 45  (18) 126  (27) .0015-155 

In each column is given the number (percent) of patients with a certain clinical feature such as age or WBC within the group of all BCR-ABL or BCR-ABL+ patients. Prefers to the comparison of each clinical parameter in BCR-ABL versus BCR-ABL+ patients.

F5-150

c-ALL and pre-B ALL only.

F5-151

P by Fisher exact text.

F5-152

P by Wilcoxon 2-sample test.

F5-153

Data for 1 patient missing.

F5-155

P by χ2 test.

F5-154

Data for 5 patients are missing.

F5-159

Data for 3 patients are missing.

or Create an Account

Close Modal
Close Modal